Xenophill Pharmaceuticals Limited
About Xenophill Pharmaceuticals Limited
Data last updated:
Xenophill Pharmaceuticals Limited is a public limited company based in Mumbai, Maharashtra, India. The company is currently under liquidation, meaning its assets are being sold to settle outstanding debts. It may not have the legal capacity to fulfil new contracts. It operates in the speciality chemicals segment of the chemicals sector. It was incorporated on 04 July 2011.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24233MH2011PLC219371.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Surender Singh Deswal and Abhimanyu Deswal.
Its last annual general meeting (AGM) was held on 30 September 2014, and its latest financial statements are for the year ended 31 March 2014. The registered office is at Galano.17 Oppdwing Vishalapartment Andheri(East), Mumbai, Maharashtra, India – 400069.
Company details
Contact details
Xenophill Pharmaceuticals Limited's registered office is in Mumbai, Maharashtra.
- Registered AddressGalano.17 Oppdwing Vishalapartment Andheri(East), Mumbai, Maharashtra, India – 400069
- IndustryChemicals, Other Chemical Product, Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Xenophill Pharmaceuticals Limited
FY 2014 filings availableFinancial Statement Summary
| Metrics | FY 2013-14 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2013-14 |
|---|---|
| Profitability | |
| EBITDA Margin | |
| Net Profit Margin | |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Xenophill Pharmaceuticals Limited, buy the company report.
Board of directors of Xenophill Pharmaceuticals Limited
Xenophill Pharmaceuticals has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bharti Deswal Also directs: Arawan Infratech LLP | Additional Director | 01 Dec 2014 | 11 Years 11 Months | As last reported |
| Surender Singh Deswal Also directs: Global Land Masters Corporation Limited, Bhoomi Infratech Private Limited, Peak View Resorts Private Limited and 1 more | Director | 04 Jul 2011 | 15 Years 4 Months | As last reported |
| Abhimanyu Deswal Also directs: Global Land Masters Corporation Limited, Bhoomi Infratech Private Limited, Peak View Resorts Private Limited and 2 more | Director | 10 Mar 2014 | 12 Years 8 Months | As last reported |
Legal cases
No court or tribunal cases involving Xenophill Pharmaceuticals Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Xenophill Pharmaceuticals Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Xenophill Pharmaceuticals Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Xenophill Pharmaceuticals Limited has 7 board changes on record since 2011: 3 appointments and 4 cessations. The latest: Bharti Deswal was appointed as Additional Director on 01 Dec 2014.
Frequently asked questions
Xenophill Pharmaceuticals is currently "Under Liquidation" as per MCA records. The company's assets are being sold to settle outstanding debts owed to creditors. A company under liquidation may not have the legal capacity to fulfil new contracts, and creditors are prioritised in the distribution of proceeds. This is a high-risk status - caution is strongly advised.
Xenophill Pharmaceuticals is a company under liquidation, formerly operating as a public limited company based in Mumbai, Maharashtra, India. The company works in other chemical product, within the chemicals industry. It was incorporated on 04 July 2011 and is registered under CIN U24233MH2011PLC219371. Caution is advised - the company may not have the legal capacity to fulfil new agreements.
Xenophill Pharmaceuticals has 3 current directors:
- Bharti Deswal - Additional Director
- Surender Singh Deswal - Director
- Abhimanyu Deswal - Director
The latest financial statements of Xenophill Pharmaceuticals on record with the MCA are for the year ended 31 March 2014. Its last annual general meeting was held on 30 September 2014. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Xenophill Pharmaceuticals is U24233MH2011PLC219371. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Xenophill Pharmaceuticals was incorporated on 04 July 2011. It is registered with the Registrar of Companies, Mumbai.
Bharti Deswal was appointed as Additional Director on 01 Dec 2014. Rajiv Kashyap ceased to be Director on 01 Dec 2014. Abhimanyu Deswal ceased to be Additional Director on 30 Sep 2014. Xenophill Pharmaceuticals has 7 board changes on record in total.
The registered office of Xenophill Pharmaceuticals is at Galano.17 Oppdwing Vishalapartment AndheriEast, Mumbai, Maharashtra, India – 400069.
Xenophill Pharmaceuticals operates in the chemicals industry, in the other chemical product segment.
Xenophill Pharmaceuticals can be reached at its registered office: Galano.17 Oppdwing Vishalapartment AndheriEast, Mumbai, Maharashtra, India – 400069.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
